Cargando…
Which Comes First, Nonalcoholic Fatty Liver Disease or Arterial Hypertension?
Non-alcoholic fatty liver disease (NAFLD) and arterial hypertension (AH) are widespread noncommunicable diseases in the global population. Since hypertension and NAFLD are diseases associated with metabolic syndrome, they are often comorbid. In fact, many contemporary published studies confirm the a...
Autores principales: | Golubeva, Julia A., Sheptulina, Anna F., Elkina, Anastasia Yu., Liusina, Ekaterina O., Kiselev, Anton R., Drapkina, Oxana M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10525922/ https://www.ncbi.nlm.nih.gov/pubmed/37760906 http://dx.doi.org/10.3390/biomedicines11092465 |
Ejemplares similares
-
Non-Alcoholic Fatty Liver Disease and Bone Tissue Metabolism: Current Findings and Future Perspectives
por: Drapkina, Oxana M., et al.
Publicado: (2023) -
Clinically Meaningful Fatigue and Depression Are Associated with Sarcopenia in Patients with Non-Alcoholic Fatty Liver Disease
por: Sheptulina, Anna F., et al.
Publicado: (2023) -
Reduced Quality of Life in Patients with Non-Alcoholic Fatty Liver Disease May Be Associated with Depression and Fatigue
por: Golubeva, Julia A., et al.
Publicado: (2022) -
Possible Mechanisms Linking Obesity, Steroidogenesis, and Skeletal Muscle Dysfunction
por: Sheptulina, Anna F., et al.
Publicado: (2023) -
Targeting Gut Microbiota as a Novel Strategy for Prevention and Treatment of Hypertension, Atrial Fibrillation and Heart Failure: Current Knowledge and Future Perspectives
por: Drapkina, Oxana M., et al.
Publicado: (2022)